Deutsche Tageszeitung - Maradona trial on hold over possible medical evidence mix-up

Maradona trial on hold over possible medical evidence mix-up


Maradona trial on hold over possible medical evidence mix-up
Maradona trial on hold over possible medical evidence mix-up / Photo: © AFP/File

The latest trial over the death of Argentine football legend Diego Maradona was suspended Thursday following claims that kidney test results presented to the court came from his father.

Change text size:

Seven health care workers are accused of criminal negligence over the care Maradona received before his death at age 60 in November 2020, while he was recuperating from brain surgery.

The first trial was dramatically annulled last year after two-and-a-half months of hearings, following revelations that one of the judges overseeing it took part in a clandestine documentary about the case.

A new trial began in April. It had been nearing a close when it, too, became embroiled in controversy.

The defense claimed that kidney test evidence produced at the trial belonged to Maradona's father, also named Diego, who died in 2015, not the star of the 1986 World Cup.

The court adjourned until August 27 to check whether the tests "correspond to Diego Armando Maradona or someone else," presiding judge Alberto Gaig said.

Maradona died of heart failure and acute pulmonary edema -- a condition where fluid accumulates in the lungs -- at a rented home in the Buenos Aires suburb of Tigre two weeks after undergoing surgery for a brain clot.

His medical team is accused of providing inadequate care in the lead-up to his death. It denies the charges.

The prosecution argued that the alleged test mix-up in no way jeopardized their case.

"They (the defense) will not succeed in bringing down the trial," prosecutor Patricio Ferrari said Thursday.

If confirmed that the test results were those of Maradona's father, however, it could discredit the medical commission set up to evaluate the circumstances of Maradona's death, boosting the defence.

The commission has been highly critical of the care Maradona received in his last days.

On Tuesday, a nephrologist testified that the former player, who had a history of cocaine abuse, was suffering from chronic kidney disease which should have acted as a red flag for his carers.

He added that the patient should have undergone daily blood tests but that there was no evidence of any blood being taken during his two weeks of home convalescence.

- Experts' credibility in question -

Agustin Varela, a lawyer for one of the accused, nurse Nancy Forlini, noted that the some of the kidney tests dated back to 2015 and could not have been Maradona the player's because he was not living in Argentina at the time.

Maradona spent most of that year in Dubai before travelling to Argentina to see his father, Diego Salustiano Maradona, who died in June 2015.

Another of Forlini's lawyers, Nicolas D'Albora however denied any plans to seek a mistrial.

"I want this case to end so that my client knows her judicial fate," he said.

(M.Travkina--DTZ)

Featured

Shana Loustau Questions Legal Validity of Complaint Against Cyril Hanouna

During a live broadcast of the M6 talk show 'Tout beau, tout neuf,' chronicleur Shana Loustau addressed public concern regarding a legal complaint filed against host Cyril Hanouna. Loustau explained that Hanouna’s mother, Esther, had expressed significant anxiety over the allegations, prompting Loustau to clarify the procedural validity of the lawsuit on air.

Chervon Names Doug Palmer Vice President of Finance - Canada

TORONTO, ON / ACCESS Newswire / November 5, 2026 / Effective November 9, 2026, Chervon names Doug Palmer Vice President of Finance - Canada, reporting to Neil Harrison, Vice President and Managing Director of Chervon Canada. He will also have a dotted-line reporting relationship to Ryan Wang, Chief Financial Officer, Chervon NA.

Polaris Renewable Energy Announces Q3 2026 Results

TORONTO, ON / ACCESS Newswire / November 5, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to report its financial and operating results for the three and nine months ended September 30, 2026. This earnings release should be read in conjunction with the Company's consolidated financial statements and management's discussion and analysis, which are available on the Company's website at www.PolarisREI.com and have been posted on SEDAR+ at www.sedarplus.ca. The dollar figures below are denominated in US Dollars unless noted otherwise.

Polaris Renewable Energy Declares Quarterly Dividend

TORONTO, ON / ACCESS Newswire / November 5, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to announce that its board of directors has declared a quarterly dividend of US$0.15 per common share outstanding.

Change text size: